Janet Tien

2.8k total citations
14 papers, 1.3k citations indexed

About

Janet Tien is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Janet Tien has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Janet Tien's work include Fibroblast Growth Factor Research (6 papers), Proteoglycans and glycosaminoglycans research (3 papers) and Melanoma and MAPK Pathways (3 papers). Janet Tien is often cited by papers focused on Fibroblast Growth Factor Research (6 papers), Proteoglycans and glycosaminoglycans research (3 papers) and Melanoma and MAPK Pathways (3 papers). Janet Tien collaborates with scholars based in United States, France and Netherlands. Janet Tien's co-authors include Andrew P. Spicer, Klaus P. Hoeflich, Lesley Murray, Howard M. Stern, David P. Davis, Daniel C. Gray, Lori S. Friedman, Somasekar Seshagiri, Leo Lap-Yan Wong and Wei Wei Prior and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Cell Biology and Cancer Research.

In The Last Decade

Janet Tien

14 papers receiving 1.2k citations

Peers

Janet Tien

ONCOL

EPIDE

Kirill V. Rosen Canada

Catherine Del Vecchio Fitz United States

Hideyuki Komekado Japan

Dianhua Qiao United States

Christine Cheng United States

Claudine Tardy France

Anjali Tikoo Australia

Li-Jyun Syu United States

Kornélia Baghy Hungary

Kirill V. Rosen Canada

Janet Tien

875 ×1.0

330 ×1.1

ONCOL

192 ×0.7

227 ×0.9

EPIDE

183 ×1.7

Citations per year, relative to Janet Tien Janet Tien (= 1×) peers Kirill V. Rosen

Countries citing papers authored by Janet Tien

Since Specialization

Citations

This map shows the geographic impact of Janet Tien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Tien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Tien more than expected).

Fields of papers citing papers by Janet Tien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Tien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Tien. The network helps show where Janet Tien may publish in the future.

Co-authorship network of co-authors of Janet Tien

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Tien. A scholar is included among the top collaborators of Janet Tien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Tien. Janet Tien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Phillips, Gail D. Lewis, Merry Nishimura, Jennifer A. Lacap, et al.. (2017). Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis. Breast Cancer Research and Treatment. 164(3). 581–591. 48 indexed citations

Yin, Yiyuan, Stevan Djakovic, Scot A. Marsters, et al.. (2015). Redesigning a Monospecific Anti-FGFR3 Antibody to Add Selectivity for FGFR2 and Expand Antitumor Activity. Molecular Cancer Therapeutics. 14(10). 2270–2278. 6 indexed citations

Du, Xiangnan, Benjamin C. Lin, Ellen Ingalla, et al.. (2014). MMP-1 and Pro-MMP-10 as Potential Urinary Pharmacodynamic Biomarkers of FGFR3-Targeted Therapy in Patients with Bladder Cancer. Clinical Cancer Research. 20(24). 6324–6335. 20 indexed citations

Asundi, Jyoti, Chae Reed, Krista McCutcheon, et al.. (2011). An Antibody–Drug Conjugate Targeting the Endothelin B Receptor for the Treatment of Melanoma. Clinical Cancer Research. 17(5). 965–975. 44 indexed citations

Kamath, Amrita V., Dan Lu, Priyanka Gupta, et al.. (2011). Preclinical pharmacokinetics of MFGR1877A, a human monoclonal antibody to FGFR3, and prediction of its efficacious clinical dose for the treatment of t(4;14)-positive multiple myeloma. Cancer Chemotherapy and Pharmacology. 69(4). 1071–1078. 21 indexed citations

Mao, Weiguang, Janet Tien, David M. Goldenberg, et al.. (2010). Abstract 4289: Early study on LGR5/GPR49 molecule as a potential colon cancer stem cell target for the antibody conjugated drug treatment. Cancer Research. 70(8_Supplement). 4289–4289. 1 indexed citations

Hoeflich, Klaus P., Sylvia Herter, Janet Tien, et al.. (2009). Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression. Cancer Research. 69(7). 3042–3051. 144 indexed citations

Qing, Jing, Xiangnan Du, Yongmei Chen, et al.. (2009). Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice. Journal of Clinical Investigation. 119(5). 1216–1229. 197 indexed citations

Degtyarev, Michael, Ann De Mazière, Christine Orr, et al.. (2008). Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. The Journal of Cell Biology. 183(1). 101–116. 347 indexed citations

10.

Hoeflich, Klaus P., Daniel C. Gray, Michael Eby, et al.. (2006). Oncogenic BRAF Is Required for Tumor Growth and Maintenance in Melanoma Models. Cancer Research. 66(2). 999–1006. 185 indexed citations

11.

Hoeflich, Klaus P., Michael Eby, W. J. Forrest, et al.. (2006). Regulation of ERK3/MAPK6 expression by BRAF. International Journal of Oncology. 29(4). 839–49. 24 indexed citations

12.

Tien, Janet & Andrew P. Spicer. (2005). Three vertebrate hyaluronan synthases are expressed during mouse development in distinct spatial and temporal patterns. Developmental Dynamics. 233(1). 130–141. 74 indexed citations

13.

Spicer, Andrew P. & Janet Tien. (2004). Hyaluronan and morphogenesis. Birth Defects Research Part C Embryo Today Reviews. 72(1). 89–108. 123 indexed citations

14.

You, Zongbing, et al.. (2004). Expression of interleukin-17B in mouse embryonic limb buds and regulation by BMP-7 and bFGF. Biochemical and Biophysical Research Communications. 326(3). 624–631. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact